CNS Drugs Journal Issues Research Articles in October 2022 Edition
October 11, 2022
October 11, 2022
CHAM, Switzerland, Oct. 11 -- CNS Drugs, a journal that says it provides researchers and healthcare professionals with information on the aspects of drug therapies used for the management of neurological and psychiatric disorders, published research articles on the following topics in its October 2022 edition:
Leading Articles:
* Bruton's Tyrosine Kinase Inhibitors in Multiple Sclerosis: Pioneering the Path Towards Treatment of Progression?
Systematic . . .
Leading Articles:
* Bruton's Tyrosine Kinase Inhibitors in Multiple Sclerosis: Pioneering the Path Towards Treatment of Progression?
Systematic . . .